How To Eliminate Asthma Disparities Together with My Canadian Pharmacy

epidemiologyIn February 2005, a national workshop was held in Chicago, IL, to examine the problem of asthma disparities. The stated goals of the workshop were as follows: (1) to review the current evidence related to eliminating asthma disparities, and highlight the successes in addressing this problem for Chicago and other US communities; and (2) to set an action agenda for accelerating solutions to this public health problem.

To achieve this goal, we assembled a multidisciplinary group of > 100 national experts in the fields of clinical research, clinical practice implementation, health-care administration, minority health, health services research, public health practice, health care financing, health policy, and consumer advocacy. In a 2-day conference, this group of experts reviewed key issues related to asthma health (http://apps.icahn.mssm.edu/asthma/) disparities; considered current research, clinical care, and policy related to this problem; and developed a practical set of recommendations (“action agenda”) to reduce these disparities by means of new research opportunities, to propose new directions in clinical and public policy, and to innovative consumer strategies to promote change.

The workshop was structured around key themes. Each theme was introduced through discussions of related background papers. Each of the background articles are presented in this supplement and include the following:

Genetics: The literature suggests that one or more asthma-related bimolecular asthma pathways may have genetic polymorphisms that may differ among minority populations.

Eliminating Asthma Disparities

asthmaThe phenomenon of inner-city asthma was identified in 1978 with the publication of a study of a special clustering of asthma mortality in a small area of Brooklyn, NY. However, it was not until the 1990s that more widespread evidence emerged that demonstrated a significant association between asthma morbidity and community socioeconomic vitality. The problem of inner-city asthma emerged from a series of publications that identified a few communities as having some of the highest asthma morbidity rates in the United States.

Chicago and New York City have been identified as being the US cities with the highest asthma mortality and hospitalization rates. Studies suggest that even in these cities, prevalence, morbidity, and mortality rates vary by neighborhood and are highest in neighborhoods with the lowest socioeconomic status. Although efforts to engage this problem have been underway across the United States, it can be argued that initiatives in Chicago and New York City have been extraordinary.